CID 169501793

Sildenafil metabolite m11

Structural Information

Molecular Formula
C21H28N6O5S
SMILES
CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)O)OCC)C
InChI
InChI=1S/C21H28N6O5S/c1-4-6-16-18-19(25(3)24-16)21(28)23-20(22-18)15-13-14(7-8-17(15)32-5-2)33(30,31)27-11-9-26(29)10-12-27/h7-8,13,29H,4-6,9-12H2,1-3H3,(H,22,23,28)
InChIKey
AYLUSVSOHVNHCJ-UHFFFAOYSA-N
Compound name
5-[2-ethoxy-5-(4-hydroxypiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,5-d]pyrimidin-7-one
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

476.1842 Da
Monoisotopic Mass

1.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 477.191476 216.4
[M+Na]+ 499.173418 225.7
[M-H]- 475.176924 217.9
[M+NH4]+ 494.218023 218.4
[M+K]+ 515.147358 218.1
[M+H-H2O]+ 459.181460 206.7
[M+HCOO]- 521.182401 221.2
[M+CH3COO]- 535.198051 230.5
[M+Na-2H]- 497.158866 214.6
[M]+ 476.18365142 220.5
[M]- 476.18474858 220.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.